Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients with Advanced Non-Small Cell Lung Cancer

Por Meriggi, F., Zaniboni, A.
Publicado em 2010

Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma.

Por Zaniboni, A., Simoncini, E., Marpicati, P., Marini, G.
Publicado em 1988

Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

Por Guglielmi, A, Barni, S, Zaniboni, A, Pella, N, Belvedere, O, Beretta, G D, Grossi, F, Frontini, L, Puglisi, F, Labianca, R, Sobrero, A
Publicado em 2004

Clinical features and long term outcome of epilepsy in periventricular nodular heterotopia. Simple compared with plus forms

Por d'Orsi, G, Tinuper, P, Bisulli, F, Zaniboni, A, Bernardi, B, Rubboli, G, Riva, R, Michelucci, R, Volpi, L, Tassinari, C, Baruzzi, A
Publicado em 2004

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients

Por Scartozzi, M, Bearzi, I, Mandolesi, A, Giampieri, R, Faloppi, L, Galizia, E, Loupakis, F, Zaniboni, A, Zorzi, F, Biscotti, T, Labianca, R, Falcone, A, Cascinu, S
Publicado em 2011

High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastr...

Por Cascinu, S, Scartozzi, M, Labianca, R, Catalano, V, Silva, R R, Barni, S, Zaniboni, A, D'Angelo, A, Salvagni, S, Martignoni, G, Beretta, G D, Graziano, F, Berardi, R, Franciosi, V
Publicado em 2004

PD-012 Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC)

Por Van Cutsem, E., Ciardiello, F., Ychou, M., Seitz, J.-F., Hofheinz, R., Arriaga, Y., Garcia-Carbonero, R., Grothey, A., Miriyala, A., Kalmus, J., Kappeler, C., Falcone, A., Zaniboni, A.
Publicado no Ann Oncol (2016)

PD-025 RECOURSE trial: impact of adverse events on quality of life and duration of TAS-102 (trifluridine and tipiracil) treatment

Por Tabernero, J., Mayer Robert, J., Ohtsu, A., Yoshino, T., Garcia-Carbonero, R., Pastorino, A., Peeters, M., Winkler, R., Makris, L., Wahba, M., Zaniboni, A., Shimada, Y., Yamazaki, K., Komatsu, Y., Hochster, H., Lenz, H.-J., Falcone, A., Tran, B., Van Cutsem, E.
Publicado no Ann Oncol (2016)

PD-009 Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO...

Por Casagrande, M., Moretto, R., Loupakis, F., Cremolini, C., Masi, G., Borelli, B., Lonardi, S., Marsico Valentina, A., Salvatore, L., Rossini, D., Ferrari, L., Ricci, V., Grande, R., Tomasello, G., Ronzoni, M., Allegrini, G., Tonini, G., Mancini, M., Zaniboni, A., Chiara, S., Carlomagno, C., Falcone, A.
Publicado no Ann Oncol (2016)